401 Avsnitt

  1. Episode 403: ADCs in Bladder Cancer. Part 2 from the Canary Islands

    Publicerades: 2025-04-02

  2. Episode 402: Uromigos en Espanol: Futuro del carcinoma de células renales

    Publicerades: 2025-03-31

  3. Episode 401: ADCs in Bladder Cancer. Part 1 from the Canary Islands

    Publicerades: 2025-03-29

  4. Episode 400: The Uromigos Score for Urothelial Cancer

    Publicerades: 2025-03-28

  5. Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?

    Publicerades: 2025-03-24

  6. Episode 398: Reflections on the Felix Feng Symposium at ASCO GU

    Publicerades: 2025-03-17

  7. Episode 397: APCCC Diagnostics Conference recap

    Publicerades: 2025-03-10

  8. Episode 396: Uromigos Japan - 激論 @JSMO25

    Publicerades: 2025-03-09

  9. Episode 395: Uromigos Japan: ASCO GU 2025のレビュー

    Publicerades: 2025-03-03

  10. Episode 394: APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

    Publicerades: 2025-03-01

  11. Episode 393: ASCO GU 2025 Review Podcast

    Publicerades: 2025-02-26

  12. Episode 392: ASCO GU 2025 - HIF Inhibition with Casdatifan in Refractory RCC

    Publicerades: 2025-02-15

  13. Episode 391: ASCO GU 2025 - KIM-1 Data from Checkmate 214

    Publicerades: 2025-02-15

  14. Episode 390: ASCO GU 2025 - Pembro-based Doublets in Refractory RCC and COSMIC-313 OS Update

    Publicerades: 2025-02-15

  15. Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer

    Publicerades: 2025-02-15

  16. Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results

    Publicerades: 2025-02-14

  17. Episode 389: ASCO GU 2025 - NIAGARA Pathologic CR Updates and Outcomes

    Publicerades: 2025-02-14

  18. Episode 386: ASCO GU 2025 - APRI Meta-analysis

    Publicerades: 2025-02-13

  19. Episode 385: ASCO GU 2025 - TALAPRO-2

    Publicerades: 2025-02-13

  20. Episode 384: ASCO GU Preview

    Publicerades: 2025-02-06

1 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site